Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

PI-2301 peptide copolymer for the treatment of autoimmune diseases, Including Multiple Sclerosis

Posted Jan 14 2009 8:24pm
Peptimmune wins new patent for peptide copolymer

1st August 2008
By Staff Writer for Pharmaceutical-Review

Peptimmune has received a US patent which protects the composition of matter for its PI-2301 peptide copolymer for the treatment of autoimmune diseases.

Peptimmune's PI-2301 is currently in a Phase Ib multiple-ascending dose, double-blind, placebo-controlled randomized study in subjects with multiple sclerosis.

» Read More



===========================================

If you want to leave a comment to this article, you need to return-to
(or remain on) - this page

============================================
Post a comment
Write a comment:

Related Searches